Literature DB >> 24898648

Alzheimer's disease-like pattern of (18)F-FDG uptake during a hyperglycemic state and negative (11)C-PiB binding in a patient with mild cognitive impairment.

Kenji Ishibashi1, Yoshiharu Miura2, Keiichi Oda3, Kiichi Ishiwata3, Kenji Ishii3.   

Abstract

Increased plasma glucose levels can cause the regional reduction of fluorine-18-labeled fluorodeoxyglucose (18F-FDG) uptake in the posterior cingulate, precuneus, and/or temporoparietal cortices as an Alzheimer's disease (AD)-like pattern. However, the association of such an AD-like pattern of cerebral 18F-FDG uptake with AD pathophysiology is unknown. We report a case of a 70-year-old patient with mild cognitive impairment, and show that the AD-like pattern of cerebral 18F-FDG uptake during a hyperglycemic state could be reversible and is not associated with amyloid-β accumulation. Our case concludes that the AD-like pattern is dependent on the plasma glucose level and independent of AD pathophysiology.

Entities:  

Keywords:  $^{11}$C-PiB; $^{18}$F-FDG; PET; hyperglycemia

Mesh:

Substances:

Year:  2014        PMID: 24898648     DOI: 10.3233/JAD-140639

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  3 in total

1.  Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading.

Authors:  Kenji Ishibashi; Kei Wagatsuma; Kiichi Ishiwata; Kenji Ishii
Journal:  Hum Brain Mapp       Date:  2016-04-08       Impact factor: 5.038

2.  Reduced uptake of 18F-FDG and 15O-H2O in Alzheimer's disease-related regions after glucose loading.

Authors:  Kenji Ishibashi; Keiichi Kawasaki; Kiichi Ishiwata; Kenji Ishii
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-10       Impact factor: 6.200

3.  Effects of glucose, insulin, and insulin resistance on cerebral 18F-FDG distribution in cognitively normal older subjects.

Authors:  Kenji Ishibashi; Airin Onishi; Yoshinori Fujiwara; Kiichi Ishiwata; Kenji Ishii
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.